- Investing Ideas
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
17
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
17 companies
Ascendis Pharma
Market Cap: US$15.1b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally.
ASND
US$244.48
7D
2.2%
1Y
48.1%
Madrigal Pharmaceuticals
Market Cap: US$12.2b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$532.02
7D
2.4%
1Y
76.4%
Insmed
Market Cap: US$31.2b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$144.48
7D
-6.7%
1Y
98.9%
Alnylam Pharmaceuticals
Market Cap: US$41.1b
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally.
ALNY
US$309.66
7D
-3.9%
1Y
32.0%
BeOne Medicines
Market Cap: US$35.9b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$323.87
7D
4.6%
1Y
40.2%
BridgeBio Pharma
Market Cap: US$14.9b
A biopharmaceutical company, discovers, develops, and delivers medicines for patients with genetic diseases.
BBIO
US$76.75
7D
2.9%
1Y
126.6%
Ionis Pharmaceuticals
Market Cap: US$12.5b
A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.
IONS
US$75.71
7D
0.7%
1Y
166.6%
AbbVie
Market Cap: US$368.6b
A research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV
US$208.38
7D
0.2%
1Y
20.5%
Jazz Pharmaceuticals
Market Cap: US$12.5b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ
US$203.42
7D
4.7%
1Y
97.9%
Eli Lilly
Market Cap: US$829.5b
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally.
LLY
US$927.03
7D
-1.3%
1Y
10.4%
Natera
Market Cap: US$29.5b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$208.40
7D
8.0%
1Y
40.7%
Royalty Pharma
Market Cap: US$29.6b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$50.00
7D
4.4%
1Y
53.4%
Viatris
Market Cap: US$17.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$14.68
7D
9.0%
1Y
94.2%
Elanco Animal Health
Market Cap: US$11.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$23.68
7D
2.4%
1Y
180.6%
Revvity
Market Cap: US$10.5b
Provides health sciences solutions, technologies, and services.
RVTY
US$93.96
7D
4.6%
1Y
2.3%
BioMarin Pharmaceutical
Market Cap: US$10.5b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN
US$54.64
7D
0.2%
1Y
-7.7%
Waters
Market Cap: US$32.2b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$327.77
7D
2.4%
1Y
2.1%